The expression of CD73 has been found to be upregulated in several types of cancers, including ovarian carcinoma, melanoma, prostate cancer, breast cancer, colon cancer, head and neck cancer, leukemia and glioblastoma (87). This evidence concerns the gene NT5E and breast carcinoma.